We produced antibodies against a synthetic peptide corresponding to amino acids 168-192 of the second exll;lceuular loop of the M2 human muscarinic receptor in rabbits. In immunoblot, affiiy-puriiied antibodies specifically recognized a major band of rat ventricular muscatiPic receptor protein with a molecular weight of about 80 KD. This recognition could be blocked by pre-incubation with peptide. Moreom, with both light (LM) and electron microscopic (EM) immunocytochemistry techaiques, m d c receptors were detected on sarcolemma and T-tubules of rat cardiomyoqw. In addition, immunoreactions were localized in membranes
Introduction
Localization of MZ muscarinic receptors has been attempted using conventional pharmacological approaches or immunocytochemistry. The conventional pharmacological approach is limited by the availability of receptor subtype-specific molecules and radioligands of high specific activity. These limitations hamper the precise identification of the receptor subtype involved in ligand binding and/or in the effect of "selective" drugs on target tissues such as brain and heart.
The successful cloning and sequencing of five subtypes of muscarinic receptors have provided molecular biological tools to induce antibodies specific for each subtype (Min et al., 1991; Peralta et al., 1987a,b) . Although these antibodies were used to selectively immunoprecipitate muscarinic receptors in several tissues, no attempt was made to use them for their immunocytochemical localization as was previously done with a monoclonal antibody raised against the purified calf brain muscarinic receptor (Raposo et al., 1987) . More recently, antibodies raised against an M2 intracellular loop-fusion protein were used to localize these receptors in rat brain of capillaries. Likewise, these reactivities were abolished by pre-incubation with peptide. These results suggest that the antibodies against the second extracellular loop of human M2 muscatidic tetcptor could specifically recognize rat ventricular muscuinic receptor protein and could be a powerful tool to study the fate of this receptor under *em pathological or physiological conditions. (]l3&" C p KEY Muxarinic receptor-2; Immunofluorescence; Electron microscopy; Peptide; Antibody. chem 4337-343,1994) and autonomic nerves by immunocytochemical means (Levey, 1993) . For each of these antibodies, no structural information was available about the antigenic determinants recognized by the antireceptor antibodies.
To produce antibodies with well-characterized antigenic determinants, we preferred to raise them against a synthetic peptide. The second extracellular loop of human M2 muscarinic receptor was used as target for the following reasons. First, the presence of predicted T-cell epitopes (Guillet et al., 1991) in this sequence theoretically allows immunization with the free peptide. This procedure decreases the probability that artifactual conformations induced by peptide coupling to a carrier protein result in production of antibodies unable to recognize the receptor. Second, the use of a longer peptide increases the probability that at least part of the peptide corresponds to a conformation present in the receptor. Third, the use of an extracellular domain allows recognition of the receptor in non-permeabilized tissue. Fourth, the successful use of synthetic peptides corresponding to the same loops in the PIand P2-adrenergic receptors can be used to localize them in rabbit heart tissue (Magnusson et al., 1989) .
The immunocytochemical potential of the antibodies raised against the second extracellular loop ofthe MZ muscarinic receptor was therefore assessed by immunofluorescence and electron microscopy on rat heart tissue in this study. 
Comparison with human MZ receptor.
Materials and Methods
Peptide. A peptide corresponding to the sequence (residues 168-192) of the second extracellular loop of the human M2 muscarinic receptor (Pcralta et al., 1987a.b ) with a cysteine as carboxy terminus (Table 1 ) was synthesized by the solid-phase method of Merrifield (1963) . using an Applied Biosrjtcms 431A automated peptide synthesizer (Foster City, CA). The pep tide was judged to be pure by HPLC analysis on a Vydac C-18 column and by amino acid analysis on an automated amino acid analyzer (Bcckman Instruments; Palo Alto, CA).
Antibody Production and Purification. Animal model and ocperimental procedure were approved by the Animal Ethical Committee of University of Gotcborg, Sweden. Two rabbits were immunized with free peptide (1 mg) emulsified in complete Freund's adjuvant and injected s c a t multiple points. Four weeks later, a booster injection (1 mg in incomplete Freund's adjuvant) was given. Rabbits were bled 1 week after the second injection. The immunoglobin fractions were prepared from sera of rabbit by precipitation in 5 % (NH4)2S04 and dialyzed extensively against PBS (10 mM phosphate. 140 mM NaCI, pH 7.4). The antiserum was further loaded on a Sepharose 4B CNBr-actimted gel (Pharmacia; Uppsala, Sweden) to which the M2 muscarinic receptor peptide was covalently linked. After washing of the immunosorbent with PBS, the specific anti-muscarinic receptor peptide antibodies were eluted with 3 M potassium thiocyanate (pH 7.4). followed by immediate extensive dialysis against PBS.
Rat Myocardium as the Soum of M2 Muscarinic Rereptors. Rat myocardium was used as the source of the M2 muscarinic acetylcholine receptor for immunobloning and immunocytochemistry as well as immunofluorescence. since heterologous systems have been previously used to demonstrate anti-receptor antibodies in human disease (Venter et al., 1980 (Venter et al., .1988 Blccher et al., 1984; Borda et al., 1984) . Moreover, the peptide we used corresponds to a sequence totally conserved in human and rat species (Peralta et al., 1987a .b) ('hble 1).
Immunoblotting Assay. Membrane proteins (75 g), prepared from rat venuiclcs according to a previously described method (Fu et al., 1991) . were subjected to electrophoresis on 10% SDS-PAGE and thereafter subjected to electrotransfer to nitrocellulose. After saturation of the nitrocellulose strips with PMT buffcr for 2 hr at room temperature (RT), the affinitypurified antibodies (10 nM) and the mouse monoclonal antibody (MAb 35) (AndrC et al.. 1984) against calf brain muscarinic receptor used as a positive control were incubated at 4'C overnight with the nitrocellulose strips. After washing in PMT. the strips were incubated with affinity-purified biotinylatcd donkey anti-rabbit IgG (diluted in PMT, 1:500) (for the rabbit antibodies) and rabbit anti-mouse IgG (for the MAb), respectively, for 1 hr at RT, followed by incubation with sueptavidin-peroxidase solution (diluted in PMT, 1:500) in the same buffer. Strips were washed in PMT and in PBS containing 0.1% Triton X-100 before addition of the chromogenic substrate H20z-4-chloro-l-naphthol. As soon as protein bands were revealed. strips were washed extensively in water and stored at -20'C. The specificity was checked by a blocking effect of the corresponding peptide (300 nM) on protein revelation after pre-incubation with antibody overnight at 4'C (Fu et al., 1993) .
fight Mi-pic ImmunocgtochemiSay. Cryostat sections (10 pm) from rat ventricles mounted on glass slides were fixed in ice-cold acetone for 10 min and then washed scqucntially with aqua bidest, PBS containing 50 mM glycine and PBG [PBS containing 0.5% bovine serum albumin (BSA) and 0.2% gelatin]. Sectionswere incubated overnight at 4'C with affinitypurified antibodies (10 nM). After three washings with PBG, the slideswere incubated with DTAF (dichlortriazinyl aminofluorcscein)-conjugated goat anti-rabbit antibodies (diluted in PBG 1:lOO) (Dianova; Hamburg, Germany) for 2 hr at RT. The preparations were washed again and then stained with DAPI (4'.6-diamidine-2'-phenylindole dihydrochloride) (Boehringer; Mannheim, Germany) for 5 min. After washing and mounting, sections were m i n e d by fluorescence and phase-contrast microscopy with appropriate filters (Zeiss Axioscop; Oberkochen. Germany). The following controls were used: (a) incubation with DX4F conjugates alone; (b) incubation with rabbit non-immune scrum (10 nM); and (c) incubation with antibodies that were pre-incubated with the corresponding synthetic peptide (300 nM) overnight at 4'C.
Hccaon Ediaoseopic hunoqtochanisay. Small pieces drat left ycntride and right atrium were fmed by immersion in a solution containing 4% formaldehyde and 0.025% glutaraldehyde in PBS for 1 hr at RT, dehydrated in a graded series of ethanol concentrations (up to loo%), and infiltrated with a mixture (1:l) of LR White resin and 100% ethanol for 1 hr. Infiltration with the resin alone took place overnight at 4'C, followed by two changes of resin the next day. In addition to LR White embedding, ultra-thin cryosections were used. For cryoultramicrotomy. specimens were infiltrated with 5% (30 min), 10% (30 min), and 2.3 M (2 hr) sucrose in PBS and frozen in liquid nitrogen. Specimens were cut with a Reichert UltracutlFC4 at -90 to -1OO'C.
For immunogold labeling, ultra-thin sections were incubated according to the a h procedure, with the following differences. Sections were incubated with affinity-purified antibody at RT for 2 hr and then with protein A-gold conjugates (diluted in PBG 1:lOO) for 1 hr at R I ' . Sections were contrasted with uranyl acetate and lead citrate and cryosections with uranyl acetate alone, followed by methylcellulose embedding, and were examined with a TESLA electron microscope.
ReSUltS

Receptor Protein Recognition with the Antibodies in Immunoblot
To confirm that the affinity-purified antibodies were able to recognize the receptor protein, immunoblots were performed on membranes prepared from rat ventricles. On electrotransferred membrane proteins of rat ventricles, the antibodies recognized a major protein band with a molecular weight of about 80 KD (Figure 1) . The band was specific for the muscarinic receptor, since the staining of this band was blocked after pre-incubation with the muscarinic receptor peptide. Moreover, this band coincided well with the band revealed by a mouse anti-muscarinic receptor MAb (AndrE et al., 1984) and a human anti-M2 muscarinic receptor autoantibody (10 nM) purified from sera of patients with idiopathic dilated cardiomyopathy (Fu et al., 1993) , and showed the same mobility as [ 3H]-propylbenzyl choline mustard (PrBCM)-labeled M2 muscarinic receptor (Haga et al., 1988) .
Light Microscopic Immunocytochemical Locdization of Rat M2 Receptors
With indirect immunofluorescence using affinity-purified antipeptide antibodies, M2 muscarinic receptors were detected not only on the surface of cardiomyocytes but also in non-cardiomyocytes, as shown by strong immunofluorescence in some areas between cardiomyocytes (Figure 2a ). This localization is specific, as it did not occur with non-immune serum (Figure 2c ) and it could be blocked by pre-incubation with the corresponding antigenic peptide (Figure 2d ).
Viewing the same section by immunofluorescence and DNAspecific DAPI counterstain, it was seen that there were some nuclei in the intercellular space indicating fluorescence-labeled non-musde cells (e.g., presumable endothelial cells) (Figure 2b) . This fluores-cence labeling is specific, as it did not occur with non-immune serum and could be blocked by pre-incubation with the corresponding peptide.
Electron Microscopic Immunocytochemirtry
Electron microscopy demonstrated the ultrastructural localization of the M2 muscarinic receptor. Immunogold labeling (15-nm gold particles) was shown to be concentrated along the sarcolemma (Figure 3a) and intracellularly between myofibrils transversely at the level of the Z-lines (Figure 3b ). From its distribution and shape, we concluded that this gold-labeled structure belongs to the T-tubule system (Figures 3c and 3d) . The sections used without specific membrane staining made exact identification of the T-tubules difficult. In addition to the gold labeling ofcardiomyocyte membranes, immunostaining of capillary endothelial cells was also seen (Figures 4a and 4b) . The gold labeling mainly marked the tissue side of the endothelial cells. The immunogold labeling was absent after pre-incubation with the corresponding peptide or with use of non-immune serum instead of the anti-peptide antibody.
Discussion
We report here that anti-peptide antibodies against the second extracellular loop of human M2 muscarinic receptor could specifically visualize rat ventricular muscarinic receptor protein in immunoblot and knmunofluomence as well as with EM immunocytochemistry.
The peptide corresponding to the sequence of the second extracellular loop of the M2 muscarinic acetylcholine receptor yielded antibodies of high titer (1:13,000). These high titers obtained by immunization with the free peptide confirmed the existence of a T-cell epitope predicted in the selected sequence. This anti-peptide antibody specifically recognized an M2 muscarinic receptor protein of about 80 KD on rat ventricularmembrane, which coincided well with the band revealed by a mouse MAb against the calf brain muscarinic receptor (MAb 35) (Andri et al., 1984) and by a human M2 muscarinic receptor autoantibody (10 nM) purified from sera of patients with idiopathic dilated cardiomyopathy (Fu et al., 1993) .
Our results demonstrated that the M2 muscarinic receptor was located mainly on the surface of cardiomyocytes, as identified by both immunofluorescence and EM. The immunofluorescence was strong on the surface of the cardiomyocytes, especially near the extracellular space and capillaries. Intercalated discs were unlabeled. With the EM post-embedding technique, the gold marker intensity was less comparable to the immunofluorescence. It is supposed that the number ofepitopes accessible for the antibodies is reduced. Only the surface of the ultra-thin section can be recognized by the antibodies. Immunoreactivity was also found on non-muscle cells in the intercellular space (Figures 2b, 4a, and 4b ), corresponding to endothelial cells. This immunoreactivity was specific for the antibody-combining site, since it was completely abolished by preincubation with the immunogenic peptide. Consequently, it could not be ascribed to Fc receptors, which are known to be present at least on mononuclear cells. The presence of immunostaining on endothelial cells should therefore also be ascribed to the presence of muscarinic receptors on these cells. Although we have no direct evidence of the subtype of these receptors, it can be assumed that they also belong to the M2 receptor subtype. Indeed, the low homology among the sequences corresponding to the extracellular loop of the five different receptor subtypes (Table 1) makes the existence of crossreacting epitopes unlikely. Moreover, the homology is mainly localized at the hydrophobic C-terminus of the peptide, which has been shown to be much less antigenic than the hydrophilic parts (Hopp and Woods, 1981) . This was confirmed by the change in the affinity of the antibodies for the peptide, in which the carboxyl groups were modified by carbodiimide (submitted for publication). Indeed, these carboxylate residues, localized at position 172-175. are completely specific for the M2 subtype.
In view of the specificity ofthe anti-peptide antibodies described and in view of the functional importance of the target domain on the receptor (Savarese et al., 1992) . they will be of value not only for the localization of the M2 muscarinic receptors in normal and diseased heart tissues but also to follow the fate of the receptor after pharmacological stimulation.
